The evolution of assays for immuno-oncology research
Drug Discovery World
FEBRUARY 15, 2023
The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. To date, several preclinical IO models have been developed, with each type having their respective strengths and weaknesses. This continues to be the standard of care.
52 
Let's personalize your content